Market closed
Oramed Pharmaceuticals/$ORMP
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Oramed Pharmaceuticals
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
Ticker
$ORMP
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
4
Website
ORMP Metrics
BasicAdvanced
$100M
Market cap
22.57
P/E ratio
$0.11
EPS
1.77
Beta
-
Dividend rate
Price and volume
Market cap
$100M
Beta
1.77
52-week high
$3.67
52-week low
$2.00
Average daily volume
172K
Financial strength
Current ratio
27.076
Quick ratio
26.987
Long term debt to equity
0.12
Total debt to equity
0.276
Interest coverage (TTM)
-6.33%
Management effectiveness
Return on assets (TTM)
-4.12%
Return on equity (TTM)
2.89%
Valuation
Price to earnings (TTM)
22.566
Price to book
0.63
Price to tangible book (TTM)
0.63
Price to free cash flow (TTM)
-12.707
Growth
Revenue change (TTM)
-100.00%
Earnings per share change (TTM)
-126.64%
What the Analysts think about ORMP
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Oramed Pharmaceuticals stock.
ORMP Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
ORMP Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Oramed Pharmaceuticals stock?
Oramed Pharmaceuticals (ORMP) has a market cap of $100M as of December 15, 2024.
What is the P/E ratio for Oramed Pharmaceuticals stock?
The price to earnings (P/E) ratio for Oramed Pharmaceuticals (ORMP) stock is 22.57 as of December 15, 2024.
Does Oramed Pharmaceuticals stock pay dividends?
No, Oramed Pharmaceuticals (ORMP) stock does not pay dividends to its shareholders as of December 15, 2024.
When is the next Oramed Pharmaceuticals dividend payment date?
Oramed Pharmaceuticals (ORMP) stock does not pay dividends to its shareholders.
What is the beta indicator for Oramed Pharmaceuticals?
Oramed Pharmaceuticals (ORMP) has a beta rating of 1.77. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.